PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Can anti-depressants help prevent Alzheimer's disease?

Penn researcher studies effects of common anti-depressant on brain peptide thought to be responsible for the development of Alzheimer's

Can anti-depressants help prevent Alzheimer's disease?
2014-05-14
(Press-News.org) PHILADELPHIA – A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD). Penn, in collaboration with investigators at Washington University, tested the drug's effects on the brain interstitial fluid (ISF) in plaque-bearing mice and the cerebrospinal fluid (CSF) of healthy human subjects to draw its conclusions, which are detailed in the new issue of Science Translational Medicine.

Alzheimer's disease is the sixth leading cause of death the United States, affecting five million patients, with the numbers expected to leap to approximately 16 million patients in the coming decades, unless preventive measures are developed.

"Our previous studies have shown an association between anti-depressants and the reduction in amyloid burden in the brain," says the paper's lead author, Yvette Sheline, MD, professor of Psychiatry, Radiology and Neurology and director of the Center for Neuromodulation in Depression and Stress, at Penn's Perelman School of Medicine. "Those studies examined a retrospective correlation between the duration of anti-depressant use and amyloid burden shown in PET scans in the brains of elderly volunteers. With this new study we took our research a step further and tested the prospective effect of the SSRI citalopram on the CSF amyloid levels in younger, healthy subjects." Sheline performed the research while at Washington University.

She again found that citalopram, which is approved by the FDA in 1998 for the treatment of depression, had significant effects.

The brain interstitial fluid (ISF) of transgenic plaque-bearing mice following exposure to citalopram showed that the level of amyloid-beta in the ISF decreased in a dose-dependent manner by as much as 25 percent compared to baseline numbers. In addition, the researchers found that two months of citalopram exposure in plaque-bearing mice resulted in no new plaque development, and no growth of existing plaques compared with a marked increase in plaque growth and development in the control group of mice, who were exposed to sugar water. However, citalopram had little effect on the regression of already existing amyloid plaques.

In a parallel study, 23 healthy human subjects, age 18 to 50 without medical disease and with no previous history of anti-depressant treatment, were administered 60 mg citalopram, roughly equivalent to the dose used in mice.

The double-blind study showed that citalopram was associated with a 38 percent lower A-beta concentration over the 37-hour testing period versus placebo, and showed a reduction in newly-produced A-beta in the citalopram-treated group versus the control group.

SSRIs are thought to produce their antidepressant effect by blocking the reuptake of the neurotransmitter serotonin into the presynaptic terminals of the neurons, increasing the availability of serotonin and reducing A-beta production. Serotonin receptor levels are reduced in brains of patients with AD. In contrast, this newly described effect on the reduction of amyloid protein concentration most likely occurs by a different pathway.

The development of safe and effective therapeutic approaches that can reduce CSF A-beta production even modestly may prevent a cascade of neuronal damage, which would have an important impact on preventing or slowing progression to symptomatic AD.

"While these results are an excellent start at lowering A-beta production, we are a long way from making a statement regarding the ability of SSRIs to prevent the cognitive decline associated with AD," Sheline says. "We are developing a greater understanding of the capabilities of SSRIs, which offer promise for the future as preventive measures, as we continue to uncover the complex mechanisms in the brain that trigger Alzheimer's and dementia."

INFORMATION:

Funding for this research was provided by NIH grants R21 AG03969002, R01 AG04140202, R01 AG042513, R21 NS082529, R01 NS067905, Washington University Hope Center for Neurological Diseases and Washington University Biomedical Mass Spectrometry Resource.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community.

[Attachments] See images for this press release:
Can anti-depressants help prevent Alzheimer's disease?

ELSE PRESS RELEASES FROM THIS DATE:

Hitting a moving target

Hitting a moving target
2014-05-14
LA JOLLA, CA—May 14, 2014—A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus—thanks to the diversity of targets the site presents to the human immune system. The finding, from a study led by scientists at The Scripps Research Institute (TSRI), is likely to influence future designs for HIV vaccines and antibody-based therapies. "We found, for example, that if the virus tries to escape from an antibody directed at that site by eliminating one of its sugars, the antibody often ...

Deformable mirror corrects errors

Deformable mirror corrects errors
2014-05-14
This news release is available in German. Lasers are used in manufacturing to cut materials or weld components together. Laser light is focused to a point using various lenses and mirrors; the smaller the focal point and the higher the energy, the more accurately operators can work with the laser. So, turn up the power and off you go, right? It is not that simple because when laser power increases, the mirror heats up accordingly, causing it to deform. A deformed mirror cannot effectively focus the laser; the focal point gets bigger and laser power falls away. Precisely ...

Victims want to change, not just punish, offenders

2014-05-14
Revenge is a dish best served with a side of change. A series of experiments conducted by researchers affiliated with Princeton University has found that punishment is only satisfying to victims if the offenders change their attitude as a result of the punishment. "Revenge is only 'sweet' if the person reacts with a change in attitude, if the person understands that what they did was wrong. It is not the act itself that makes punishment satisfying," said Friederike Funk, a Princeton graduate student in psychology and one of the researchers. The findings offer insights ...

Study shows breastfeeding, birth control may reduce ovarian cancer risk in women with BRCA mutations

2014-05-14
PHILADELPHIA — Breastfeeding, tubal ligation – also known as having one's "tubes tied" – and oral contraceptives may lower the risk of ovarian cancer for some women with BRCA gene mutations, according to a comprehensive analysis from a team at the University of Pennsylvania's Basser Research Center for BRCA and the Abramson Cancer Center. The findings, a meta-analysis of 44 existing peer-reviewed studies, are published in the Journal of the National Cancer Institute. The researchers, from Penn's Perelman School of Medicine, found that breastfeeding and tubal ligation ...

New insight into thermoelectric materials may boost green technologies

New insight into thermoelectric materials may boost green technologies
2014-05-14
Coral Gables, Fla. (May 15, 2014) — Thermoelectric materials can turn a temperature difference into an electric voltage. Among their uses in a variety of specialized applications: generating power on space probes and cooling seats in fancy cars. University of Miami (UM) physicist Joshua Cohn and his collaborators report new surprising properties of a metal named lithium purple-bronze (LiPB) that may impact the search for materials useful in power generation, refrigeration, or energy detection. The findings are published in the journal Physical Review Letters. "If current ...

SapC-DOPS technology may help with imaging brain tumors, research shows

2014-05-14
Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat—both adult and pediatric patients have a five-year survival rate of only 30 percent—but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process. However, Cincinnati Cancer Center and University of Cincinnati Cancer Institute research studies published in an April online issue of the Journal of Magnetic Resonance Imaging and a May issue of ...

How cone snail venom minimizes pain

How cone snail venom minimizes pain
2014-05-14
The venom from marine cone snails, used to immobilize prey, contains numerous peptides called conotoxins, some of which can act as painkillers in mammals. A recent study in The Journal of General Physiology provides new insight into the mechanisms by which one conotoxin, Vc1.1, inhibits pain. The findings help explain the analgesic powers of this naturally occurring toxin and could eventually lead to the development of synthetic forms of Vc1.1 to treat certain types of neuropathic pain in humans. Neuropathic pain, a form of chronic pain that occurs in conjunction with ...

Scientists test hearing in Bristol Bay beluga whale population

Scientists test hearing in Bristol Bay beluga whale population
2014-05-14
The ocean is an increasingly industrialized space. Shipping, fishing, and recreational vessels, oil and gas exploration and other human activities all increase noise levels in the ocean and make it more difficult for marine mammals to hear and potentially diminish their range of hearing. "Hearing is the main way marine mammals find their way around the ocean," said Aran Mooney, a biologist at Woods Hole Oceanographic Institution (WHOI). It's important to know whether and to what extent human activity is negatively impacting them. But how can we get marine mammals living ...

Snubbing lion hunters could preserve the endangered animals

2014-05-14
For hundreds of years young men from some ethnic groups in Tanzania, called "lion dancers" because they elaborately acted out their lion killing for spectators, were richly rewarded for killing lions that preyed on livestock and people. Now when a lion dancer shows up he might be called a rude name rather than receive a reward, according to a new UC Davis study. Some villagers are snubbing the lion killers, calling them "fakers" and contemplating punishing them and those who continue to reward them, said Monique Borgerhoff Mulder, anthropology professor at UC Davis. ...

Deconstructing goal-oriented movement

Deconstructing goal-oriented movement
2014-05-14
Our human brains are filled with maps: visual maps of our external environments, and motor maps that define how we interact physically within those environments. Somehow these separate points of reference need to correspond with — and to — one another in order for us to act, whether it's grasping a coffee cup or hitting a tennis ball. How that happens is the focus of a new study by scientists at UC Santa Barbara. The researchers used neuroimaging to decode how the brain transforms sensory input into action. Their findings are reported in the Journal of Neuroscience. ...

LAST 30 PRESS RELEASES:

Premenstrual symptoms linked to increased risk of cardiovascular disease

Newly discovered remains of ancient river landscapes control ice flow in East Antarctica

Newly discovered interstellar object 'may be oldest comet ever seen'

Animal-inspired AI robot learns to navigate unfamiliar terrain

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

[Press-News.org] Can anti-depressants help prevent Alzheimer's disease?
Penn researcher studies effects of common anti-depressant on brain peptide thought to be responsible for the development of Alzheimer's